iMGP Global Partner, an investment management company, has released an investor prospectus for the fourth quarter of 2025 for “iMGP small company fund”. A copy of the book can be downloaded here. The fund returned 1.33% in the fourth quarter compared to the Russell 2000 Index’s return of 2.19%. The Fund’s returns were low at 0.01% in 2025, compared to a 12.81% return for the Index. In many ways, market conditions returned to normal in the fourth quarter. The Fund’s poor performance in the fourth quarter was due to the impressive performance of biotech businesses, which rose more than 25%. The fund generally avoids biotech stocks because of their highly volatile nature. The worst performance of the year occurred in the third quarter due to stylistic factors. Moving forward to 2026, the Fund hopes to continue to refine its process and improve its performance by committing to investing in growing, high-quality industries. Please review the Fund’s top five holdings for details on their key options for 2025.
In its investor note for the fourth quarter of 2025, iMGP Small Company Fund highlighted United States Antimony Corporation (AMEX:UAMY). United States Antimony Corporation (AMEX:UAMY) is a mining and specialty company active in the Antimony and Zeolite sectors. On March 09, 2026, United States Antimony Corporation (AMEX:UAMY) stock closed at $9.60 per share. United States Antimony Corporation (AMEX:UAMY)’s one-month return was 17.79%, and its shares gained 566.67% in the last 52 weeks. United States Antimony Corporation (AMEX:UAMY) has a market capitalization of $1.344 billion.
iMGP Small Company Fund said the following about United States Antimony Corporation (AMEX:UAMY) in its fourth quarter 2025 investor letter:
“United States Antimony Corporation (AMEX:UAMY) was the top contributor. UAMY took advantage of the antimony export ban for military use in China by winning a $245 million five-year cash-only contract to rebuild US antimony. Given the volatility of the name and the speed with which it is appreciated, as well as the additional announcements of new investments in antinomy processing by other players, we are out of this name. “
United States Antimony Corporation (AMEX:UAMY) is not on our list of the 40 Most Popular Stocks Among Hedge Funds Entering 2026. According to our database, 18 hedge fund portfolios held United States Antimony Corporation (AMEX:UAMY) at the end of the fourth quarter, up from 12 in the previous quarter. While we recognize the potential of United States Antimony Corporation (AMEX:UAMY) as an investment, we believe certain AI stocks offer greater potential and carry less downside risk. If you’re looking for an extremely overlooked AI stock that will benefit greatly from the Trump-era costs and sea trend, check out our free report best short term AI stock.
